According to the EY-Parthenon GLP-1 Consumer Survey (March 2025), 44% of users drink less after starting GLP-1 and 82% keep those habits even after stopping treatment
Heavy metal detoxification: Glutathione conjugation is a primary pathway for detoxifying mercury, arsenic, cadmium, and lead
67 This is also supported by a recent secondary analyses of the Look-AHEAD (Action for Health in Diabetes) trial, showing racial and social-economic status disparities in the use of innovative glucose lowering medications (ie, DPP-4i, or SGLT-2i or GLP-1RAs)
Take home message Eli Lilly reported on 21 May 2026 that retatrutide produced an average weight loss of up to 30.3% in its Phase 3 TRIUMPH-1 trial, the largest figure reported so far for a weight-loss injection
The right choice is individual, and you can switch if one is not the best fit